Immunocore (IMCR) announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous ...

For more than a decade, patient recruitment and retention have been persistent hurdles in clinical research and are consistently cited as the biggest operational challenges with r ...

Martei is a medical oncologist, cancer outcomes researcher, and an assistant professor of medicine at the University of Pennsylvania. At the American Society of Clinical Oncology annual meeting last ...

Different groups of people—men, women, children, and people of different races or ethnic backgrounds—respond differently to different drugs. Clinical trials are supposed to drive advances in medicine ...

"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...

Over the past few years, we’ve seen a wave of digital innovation in clinical trials: decentralized models, eConsent, real-time monitoring and direct-to-patient logistics. We’ve digitized nearly every ...

Nearly 1 in 30 clinical trials were interrupted by funding cuts to the National Institutes of Health, affecting more than 74,000 patients and research into cancer, infectious disease and more, ...

Photo-Illustration by Chloe Dowling for TIME (Source Images: Maki Nakamura—Getty Images, Tara Moore—Getty Images, We Are/Getty Images, Leland Bobbe—Getty Images, Willie B. Thomas—Getty Images, Morsa ...

In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, examines the most common threats to trial data reliability ...